PALO ALTO, Calif., Sept. 12, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that updated data from the clinical development program for its investigational therapy KSI-301 will be presented at The Retina Society Annua

PLEASANTON, Calif., Sept. 12, 2019 /PRNewswire/ -- Shaklee Corporation was honored to feature Wayne Westcott, Ph.D. as a keynote speaker at the Science Symposium held as part of its 2019 Global Conference in July. Dr. Westcott shared the results of three Shaklee-funded research studies. Two of these were also featured in his presentati

CAMBRIDGE, Mass., Sept. 12, 2019 /PRNewswire/ -- East Lancashire Hospitals NHS Trust (ELHT), a large integrated healthcare organization serving over a half million patients in north west England, has joined the TriNetX global health research network to improve its research intelligence capabilities, bring more research opportunities to it

SAN DIEGO, Sept. 12, 2019 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced that the Toca 5 Phase 3, randomized, multi-center clinic

WOODBURY, Minn., Sept. 12, 2019 /PRNewswire/ -- Self Esteem Brands, the parent company of Anytime Fitness, has purchased The Bar Method – a popular, low-impact fitness franchise with 123 studio

WASHINGTON, Sept. 12, 2019 /PRNewswire/ -- Nine U.S. states had adult obesity rates above 35 percent in 2018, up from seven states at that level in 2017, an historic level of obesity in the U.S., according to the 16th annual State of Obesity: Better Policies for a Healthier America report released today by the Trust for America's Health (TFAH).

BASEL, Switzerland, Sept. 12, 2019 /PRNewswire/ -- Strekin AG (www.strekin.com), a biopharmaceutical company focused on treatments for hearing loss, announced today that it has successfully completed patient recruitment in the RESTORE study, an international, randomized, placebo-controlled, Phase 3 clin

GOTHENBURG, Sweden, Sept. 12, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced that an abstract highlighting the study design of its ongoing pivotal/registration-based AGENT clinical study (ISO-CC-007) in metastatic colorectal cancer (mCRC) will be presented at the European Society for Medical Oncology

TEL AVIV, Israel, Sept. 12, 2019 /PRNewswire/ -- Today, Healthy.io, the global leader in turning the smartphone camera into a clinical-grade medical device, announced it has

INCLINE VILLAGE, Nev., Sept. 11, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announced that the Supreme Court of New York, County of New York, Commercial Division, issued its decision today in PDL's previously disclosed litigation related to defaults by Wellstat Di